Rob Etherington has held a variety of roles over his 21 years in the pharmaceutical industry. Rob is the former senior vice president in charge of commercial operations at Actelion Pharmaceuticals US, Inc, which he joined in its founding year of commercialization as its first marketing officer. During his 13-year tenure at Actelion, Rob presided over the commercialization activities as Actelion grew into a $7+ billion market-cap company with annual sales of nearly $2 billion across a portfolio of 4 approved drugs, including Tracleer (2000-2013). Rob also served as an officer of Actelion Pharmaceuticals US, Inc, and on the US Executive Board. Before joining Actelion, Rob served as a marketing leader at Pfizer (Parke-Davis Division, Warner-Lambert Company) with key responsibilities in the launch years for Lipitor and Rezulin. Rob is an alumnus of the Harvard Business School General Management Program, and he holds an MBA from the Marriott School at Brigham Young University.